7th EUROD WINTER MEETING 2024 - Recordings are now available!

The 7th EUROD Winter Meeting was held in Leuven, Belgium from Jan 17 to 19 - and the meeting was was also live-streamed. Recordings are now available here!

You can also find the link on the ERA CKD-BMD Working group website, under ‘Events organized by CKD-MBD’.

Review the available program below: 

Thursday Jan 17: 
Clinical Hot Topics

• The recommended calcium intake in CKD – a European consensus (Hanne Skou Jørgensen, Aalborg University Hospital, Denmark)
• DXA vs REMS: Differences and advantages (Giuseppe Guglielmi, Foggia University, Italy)
• Bone biomarkers: a glimpse into the future (Etienne Cavalier, University of Liège, Belgium)
• Novel and sequential pharmacological approaches in osteoporosis: how to apply in CKD (Tom Nickolas, Columbia University, New York, US)

Friday Jan 18: 
Satellite symposium – mineral metabolism and bone in rare renal diseases

• Throw me a bone: alkali in distal renal tubular acidosis (Detlef Bockenhauer, KU Leuven, Belgium)
• Bone impairment in nephropathic cystinosis (Justine Bacchetta, University of Lyon, France)
• Linked Hypophosphatemia (Marie-Helene Lafage-Proust, University of Lyon, St.Etienne, France)

Research Forum, part 1

• Molecular diagnostics in CKD-MBD (Sara Fernández-Villabrille, Central University Hospital of Asturias, Oviedo, Spain)
• PTEN ablation in osteocytes modifies CKD-MBD parameters and affects red blood cell homeostasis in mice with renal insufficiency (Juan Miguel Díaz Tocados, Biomedical Research Institute of Lleida, Spain)
• A distinct bone and mineral phenotype in chronic kidney disease patients treated with peritoneal dialysis (Maria Jesus Lloret, Hospital Fundació Puigvert, Barcelona, Spain)
• Male gonadal dysfunction and CKD-MBD (Karel David, KU Leuven, Belgium)
• Hypoxia-driven pathways in bone development, regeneration and disease (Christa Maes, KU Leuven, Belgium)

Research Forum, part 2

• C-terminal FGF23 and its function in iron metabolism (Guillaume Courbon, University of Lyon, St.Etienne, France)
• HIF stabilizers and CKD-MBD (Marc Vervloet, Radboud UMC, Nijmegen, the Netherlands)
• Endothelial calcification induced by high phosphate is characterized by mesenchymal and osteoblastic differentiation (Paola Ciceri, University of Milan, Italy)
• Mice with conditional Vdr deletion in renal tubules remain normocalcemic with minimal effects on bone homeostasis (Lieve Verlinden, KU Leuven, Belgium)
• Spatial transcriptomics – advances and applications in bone research (Thomas Levin Andersen, Odense University, Denmark)

Friday jan 19: 
CME – Inflammation and CKD (–MBD)

• The essentials of sterile inflammation in CKD (Thimoteus Speer, Goethe University Hospital, Frankfurt, Germany)
• Gut dysbiosis as a cause of inflammation in CKD (Pieter Evenepoel, UZ/KU Leuven, Belgium)
• Inflammation and vascular calcification (Cathy Shanahan, King’s College, London, UK)
• Inflammation and bone loss: lessons from osteoimmunology and osteomicrobiology (Roberto Pacifici, Emory University, Atlanta, US
• Inflammation and kidney disease progression (Alberto Ortiz, Jiménez Díaz Foundation University Hospital, Madrid, Spain)
• EPO resistance in CKD: inflammation and beyond (Lucia Del Vecchio, Hospital Sant'Anna, Como, Italy)
• Nutritional and pharmacological treatment options to tackle inflammation in CKD (Peter Stenvinkel, Karolinska Institute, Stockholm, Sweden)

Save the date for the next EUROD Winter Meeting: January 15-17, 2025!